Delivery Order SPE2DB20D3103-SPE2DB25FP6M8
Award Date 7/25/25
Potential Completion Date 8/15/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,436.04 firm fixed price delivery order is for 1,400 mg-23,400 11.7 ml units of the medication Rituxan Hycela. The contract has a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which provides a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $29,254.08 firm fixed price contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug RITUXAN HYCELA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price delivery order is for RITUXAN HYCELA 1,400 MG-23,400 11.7ML, with a period of performance through July 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,664.56, is for the delivery of Rituxan Hycela, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela, with a ceiling value of $74,092.00 and a completion date of June 7, 2023. The contract was awarded on May 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price contract is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML medical supplies. The contract has a period of performance through July 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award (SPE2DB20D3103|SPE2DB22FM4X7) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,400 mg-23,400 11.7 ml units of the drug Rituxan Hycela. The contract has a ceiling value of $11,738.44 and was awarded on a firm fixed-price basis, with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,308.18 for 400 mg Benlysta vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,944.43 on July 21, 2025, for the supply of Benlysta 400 mg vials to support federal medical procurement needs. The contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's...